Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
The price of Medpace Holdings Inc (NASDAQ: MEDP) closed at $297.73 in the last session, down -2.28% from day before closing price of $304.69. In other words, the price has decreased by -$2.28 from its previous closing price. On the day, 0.61 million shares were traded. MEDP stock price reached its highest trading level at $307.345 during the session, while it also had its lowest trading level at $295.43.
Ratios:
We take a closer look at MEDP’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 13.55 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 15.85. For the most recent quarter (mrq), Quick Ratio is recorded 0.93 and its Current Ratio is at 0.93. In the meantime, Its Debt-to-Equity ratio is 0.18 whereas as Long-Term Debt/Eq ratio is at 0.15.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Leerink Partners on March 24, 2025, initiated with a Market Perform rating and assigned the stock a target price of $330.
On October 23, 2024, Robert W. Baird Downgraded its rating to Neutral which previously was Outperform and also lowered its target price recommendation from $413 to $349.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Feb 27 ’25 when EWALD STEPHEN P bought 2 shares for $326.11 per share. The transaction valued at 652 led to the insider holds 13,343 shares of the business.
Carley Brian T sold 4,003 shares of MEDP for $1,383,397 on Feb 24 ’25. The Director now owns 26,032 shares after completing the transaction at $345.59 per share. On Feb 24 ’25, another insider, Carley Brian T, who serves as the Director of the company, bought 4,003 shares for $345.59 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MEDP now has a Market Capitalization of 9070880768 and an Enterprise Value of 8550969344. As of this moment, Medpace’s Price-to-Earnings (P/E) ratio for their current fiscal year is 23.57, and their Forward P/E ratio for the next fiscal year is 21.78. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.13. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.30 while its Price-to-Book (P/B) ratio in mrq is 11.02. Its current Enterprise Value per Revenue stands at 4.054 whereas that against EBITDA is 17.96.
Stock Price History:
The Beta on a monthly basis for MEDP is 1.46, which has changed by -0.24838436 over the last 52 weeks, in comparison to a change of 0.08089435 over the same period for the S&P500. Over the past 52 weeks, MEDP has reached a high of $459.77, while it has fallen to a 52-week low of $289.01. The 50-Day Moving Average of the stock is -10.96%, while the 200-Day Moving Average is calculated to be -16.07%.
Shares Statistics:
According to the various share statistics, MEDP traded on average about 330.77K shares per day over the past 3-months and 400880 shares per day over the past 10 days. A total of 30.56M shares are outstanding, with a floating share count of 24.67M. Insiders hold about 19.01% of the company’s shares, while institutions hold 84.53% stake in the company. Shares short for MEDP as of 1741910400 were 1242942 with a Short Ratio of 3.76, compared to 1739491200 on 1247802. Therefore, it implies a Short% of Shares Outstanding of 1242942 and a Short% of Float of 6.18.
